In a recent statement, the regenerative medicine company Orthocell is proud to announce their patent for “Suture-less Repair of Soft Tissue” has gone through. This of course refers to the method repairing damaged soft tissue without needing to stitch the wound shut. It’s an exciting time to be in the medical world as Managing Director of Orthocell, Paul Anderson had this to say, “This is an important addition to our current global IP portfolio. Not only does it further strengthen our IP position in regenerative medicine products and surgical techniques for soft tissue repair, but it also acts to validate CelGro as a collagen medical device platform. The company believes that this innovation has the potential to offer a wider application range in existing markets like bones, tendons, nerves, and even cartilage reconstruction. Looks to me like this is an exciting day for the medical field!
